AMANTADINE HYDROCHLORIDE | A078720 | BIONPHARMA INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Strides Pharma, Inc. FDA-2016-P-2713 · 3 docket documents Strides Pharma, Inc. filed this citizen petition under Section 505(j) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA designate an approved generic version of Amantadine Hydrochloride soft gelatin capsule 100 mg as a reference listed drug. The petitioner seeks this designation be | Other | 2016-09-14 | Withdrawn | Strides Pharma, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.1622
per ea
Lowest NADAC/Unit
$0.1622
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 69452014220AMANTADINE 100 MG CAPSULE | $0.1622 | EA | Generic | — | 2026-06-17 |
| 50268006915AMANTADINE 100 MG CAPSULE | $0.1622 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.